XLS Stock Chart & Stats
CHF14.40
-CHF0.60(-3.51%)
At close: 4:00 PM EDT
CHF14.40
-CHF0.60(-3.51%)
Day’s Range― - ―
52-Week RangeCHF13.65 - CHF26.80
Previous CloseN/A
Volume2.79K
Average Volume (3M)2.10K
Market Cap
CHF81.90M
Enterprise ValueCHF262.06M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)2.6
Beta0.27
Next Earnings
Sep 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding5,767,572
10 Day Avg. Volume3,275
30 Day Avg. Volume2,104
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-2.37
Revenue Forecast (FY)CHF800.00K
Xlife Sciences Ltd. News
XLS FAQ
What was Xlife Sciences Ltd.’s price range in the past 12 months?
Xlife Sciences Ltd. lowest stock price was CHF13.65 and its highest was CHF26.80 in the past 12 months.
What is Xlife Sciences Ltd.’s market cap?
Xlife Sciences Ltd.’s market cap is CHF81.90M.
When is Xlife Sciences Ltd.’s upcoming earnings report date?
Xlife Sciences Ltd.’s upcoming earnings report date is Sep 30, 2026 which is in 29 days.
How were Xlife Sciences Ltd.’s earnings last quarter?
Xlife Sciences Ltd. released its earnings results on Sep 23, 2025. The company reported -CHF0.531 earnings per share for the quarter.
Is Xlife Sciences Ltd. overvalued?
According to Wall Street analysts Xlife Sciences Ltd.’s price is currently Overvalued.
Does Xlife Sciences Ltd. pay dividends?
Xlife Sciences Ltd. does not currently pay dividends.
What is Xlife Sciences Ltd.’s EPS estimate?
Xlife Sciences Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Xlife Sciences Ltd. have?
Xlife Sciences Ltd. has 5,767,572 shares outstanding.
What happened to Xlife Sciences Ltd.’s price movement after its last earnings report?
Xlife Sciences Ltd. reported an EPS of -CHF0.531 in its last earnings report. Following the earnings report the stock price went up 4.286%.
Which hedge fund is a major shareholder of Xlife Sciences Ltd.?
Currently, no hedge funds are holding shares in CH:XLS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Xlife Sciences Ltd.
Xlife Sciences AG is a Swiss company with a focus on performance technologies in life sciences. The company allows its investors a very early and direct Entry into the further development of innovative and future-oriented technologies.
Technical Analysis
Addex Therapeutics
―
Molecular Partners AG
―
Basilea Pharmaceutica
―
Newron Pharmaceuticals SpA
―
Santhera Pharmaceuticals Holding
―